Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds

NCT: NCT07856797 · NOT_YET_RECRUITING

NCT IDNCT07856797
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2029-02
SponsorMerz North America, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to confirm the long-term safety, effectiveness, and degradation profile of RADIESSE® Injectable Implant for the correction of moderate to severe nasolabial folds (NLFs) in Chinese adults. Eligible participants will receive treatment with RADIESSE® Injectable Implant in both NLFs and may receive an optional touch-up treatment at Month 1 at investigator's discretion. Participants will be followed for up to 24 months after last treatment.

Frequently Asked Questions

What is A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds?

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds is a clinical trial registered under NCT07856797. Current status: NOT_YET_RECRUITING.

What is the status of NCT07856797?

The current status of NCT07856797 (A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds) is: NOT_YET_RECRUITING.

When did A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds start?

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds started on 2026-10.

Related Devices

K172689DESCRIBE PFD PatchMerz North America, Inc. PMA P040047AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USEMerz North America, Inc. PMA P050037Implant, dermal, for aesthetic useMerz North America, Inc. PMA P050052Implant, dermal, for aesthetic useMerz North America, Inc. PMA P090016Implant, dermal, for aesthetic useMerz North America, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑